These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31673011)

  • 21. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
    Ravimohan S; Tamuhla N; Nfanyana K; Steenhoff AP; Letlhogile R; Frank I; MacGregor RR; Gross R; Weissman D; Bisson GP
    Clin Infect Dis; 2016 Mar; 62(6):795-803. PubMed ID: 26611774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL7RA polymorphisms predict the CD4+ recovery in HIV patients on cART.
    Guzmán-Fulgencio M; Berenguer J; Jiménez-Sousa MA; Micheloud D; García-Álvarez M; Bellón JM; Aldámiz-Echevarría T; García-Broncano P; Catalán P; Diez C; Pineda-Tenor D; Resino S
    Eur J Clin Invest; 2015 Nov; 45(11):1192-9. PubMed ID: 26402121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammation Perturbs the IL-7 Axis, Promoting Senescence and Exhaustion that Broadly Characterize Immune Failure in Treated HIV Infection.
    Shive CL; Clagett B; McCausland MR; Mudd JC; Funderburg NT; Freeman ML; Younes SA; Ferrari BM; Rodriguez B; McComsey GA; Calabrese LH; Sieg SF; Lederman MM
    J Acquir Immune Defic Syndr; 2016 Apr; 71(5):483-92. PubMed ID: 26627102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of suboptimal CD4
    Handoko R; Colby DJ; Kroon E; Sacdalan C; de Souza M; Pinyakorn S; Prueksakaew P; Munkong C; Ubolyam S; Akapirat S; Chiarella J; Krebs S; Sereti I; Valcour V; Paul R; Michael NL; Phanuphak N; Ananworanich J; Spudich S;
    J Int AIDS Soc; 2020 Sep; 23(9):e25585. PubMed ID: 32949118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART.
    Marziali M; De Santis W; Carello R; Leti W; Esposito A; Isgrò A; Fimiani C; Sirianni MC; Mezzaroma I; Aiuti F
    AIDS; 2006 Oct; 20(16):2033-41. PubMed ID: 17053349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recovery of CD4+ T Cells in HIV patients with a stable virologic response to antiretroviral therapy is associated with polymorphisms of interleukin-6 and central major histocompatibility complex genes.
    Fernandez S; Rosenow AA; James IR; Roberts SG; Nolan RC; French MA; Price P
    J Acquir Immune Defic Syndr; 2006 Jan; 41(1):1-5. PubMed ID: 16340466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The IL-7/IL-7 receptor axis: understanding its central role in T-cell homeostasis and the challenges facing its utilization as a novel therapy.
    Sasson SC; Zaunders JJ; Kelleher AD
    Curr Drug Targets; 2006 Dec; 7(12):1571-82. PubMed ID: 17168832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low CD4 T-cell counts despite low levels of circulating HIV: insights from the comparison of HIV-1 infected patients with a discordant response to antiretroviral therapy to patients with untreated advanced HIV-2 disease.
    Albuquerque AS; Foxall RB; Cortesão CS; Soares RS; Doroana M; Ribeiro A; Lucas M; Antunes F; Victorino RM; Sousa AE
    Clin Immunol; 2007 Oct; 125(1):67-75. PubMed ID: 17692571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The kynurenine pathway of tryptophan catabolism, CD4+ T-cell recovery, and mortality among HIV-infected Ugandans initiating antiretroviral therapy.
    Byakwaga H; Boum Y; Huang Y; Muzoora C; Kembabazi A; Weiser SD; Bennett J; Cao H; Haberer JE; Deeks SG; Bangsberg DR; McCune JM; Martin JN; Hunt PW
    J Infect Dis; 2014 Aug; 210(3):383-91. PubMed ID: 24585899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased number of CD4+ and CD8+ T cells that express the interleukin-7 receptor in blood and tissues of SIV-infected macaques.
    Moniuszko M; Edghill-Smith Y; Venzon D; Stevceva L; Nacsa J; Tryniszewska E; Tsai WP; Franchini G
    Virology; 2006 Dec 5-20; 356(1-2):188-97. PubMed ID: 16934309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin 7 up-regulates CD95 protein on CD4+ T cells by affecting mRNA alternative splicing: priming for a synergistic effect on HIV-1 reservoir maintenance.
    Yin Y; Zhang S; Luo H; Zhang X; Geng G; Li J; Guo X; Cai W; Li L; Liu C; Zhang H
    J Biol Chem; 2015 Jan; 290(1):35-45. PubMed ID: 25411246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Interleukin-28B polymorphism on Interleukin-28 expression and immunological recovery amongst HIV-1-infected individuals following antiretroviral therapy.
    Srinidhi BV; Fletcher GJ; Sachidanantham J; Rupali P; Ramalingam VV; Demosthenes JP; Abraham OC; Pulimood SA; Rebekah G; Kannangai R
    Indian J Med Microbiol; 2017; 35(4):580-584. PubMed ID: 29405153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced plasma levels of soluble interleukin-7 receptor during graft-versus-host disease (GVHD) in children and adults.
    Poiret T; Rane L; Remberger M; Omazic B; Gustafsson-Jernberg A; Vudattu NK; Ahmed R; Ernberg I; Winiarski J; Magalhaes I; Ringden O; Maeurer M
    BMC Immunol; 2014 Jun; 15():25. PubMed ID: 24946690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy.
    Hunt PW; Cao HL; Muzoora C; Ssewanyana I; Bennett J; Emenyonu N; Kembabazi A; Neilands TB; Bangsberg DR; Deeks SG; Martin JN
    AIDS; 2011 Nov; 25(17):2123-31. PubMed ID: 21881481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pilot study evaluating time to CD4 T-cell count <350 cells/mm(3) after treatment interruption following antiretroviral therapy +/- interleukin 2: results of ACTG A5102.
    Henry K; Katzenstein D; Cherng DW; Valdez H; Powderly W; Vargas MB; Jahed NC; Jacobson JM; Myers LS; Schmitz JL; Winters M; Tebas P;
    J Acquir Immune Defic Syndr; 2006 Jun; 42(2):140-8. PubMed ID: 16760795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial.
    Davey RT; Murphy RL; Graziano FM; Boswell SL; Pavia AT; Cancio M; Nadler JP; Chaitt DG; Dewar RL; Sahner DK; Duliege AM; Capra WB; Leong WP; Giedlin MA; Lane HC; Kahn JO
    JAMA; 2000 Jul; 284(2):183-9. PubMed ID: 10889591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunophenotype of HIV+ patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system.
    Nemes E; Lugli E; Nasi M; Ferraresi R; Pinti M; Bugarini R; Borghi V; Prati F; Esposito R; Cossarizza A; Mussini C
    AIDS; 2006 Oct; 20(16):2021-32. PubMed ID: 17053348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The correlation between levels of IL-7Ralpha expression and responsiveness to IL-7 is lost in CD4 lymphocytes from HIV-infected patients.
    Colle JH; Moreau JL; Fontanet A; Lambotte O; Delfraissy JF; Thèze J
    AIDS; 2007 Jan; 21(1):101-3. PubMed ID: 17148974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug Use is Associated with Anti-CD4 IgG-mediated CD4+ T Cell Death and Poor CD4+ T Cell Recovery in Viral-suppressive HIV-infected Individuals Under Antiretroviral Therapy.
    Jiang W; Luo Z; Martin L; Wan Z; Fu P; Wagner A; Ling B; Heath SL; Haque A; McRae-Clark A
    Curr HIV Res; 2018; 16(2):143-150. PubMed ID: 29968539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy.
    Routy JP; Angel JB; Patel M; Kanagaratham C; Radzioch D; Kema I; Gilmore N; Ancuta P; Singer J; Jenabian MA
    HIV Med; 2015 Jan; 16(1):48-56. PubMed ID: 24889179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.